CIM
BMY icon

CIM Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

CIM Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$873K Sell
14,397
-64
-0.4% -$3.73K 0.23% 69
2025
Q4 		$780K Hold
14,461
– – 0.2% 85
2025
Q3 		$652K Sell
14,461
-14,810
-51% -$692K 0.18% 96
2025
Q2 		$1.51M Buy
29,271
+14,611
+100% +$717K 0.29% 71
2025
Q1 		$894K Sell
14,660
-12
-0.1% -$699 0.2% 69
2024
Q4 		$830K Sell
14,672
-74
-0.5% -$4.13K 0.24% 72
2024
Q3 		$763K Sell
14,746
-428
-3% -$20.1K 0.23% 86
2024
Q2 		$630K Sell
15,174
-141
-0.9% -$6.31K 0.19% 101
2024
Q1 		$831K Hold
15,315
– – 0.25% 77
2023
Q4 		$786K Hold
15,315
– – 0.25% 79
2023
Q3 		$889K Sell
15,315
-334
-2% -$20.5K 0.33% 59
2023
Q2 		$1M Buy
15,649
+31
+0.2% +$2.08K 0.34% 58
2023
Q1 		$1.08M Buy
15,618
+6,165
+65% +$435K 0.4% 40
2022
Q4 		$680K Sell
9,453
-9,985
-51% -$753K 0.27% 72
2022
Q3 		$1.38M Hold
19,438
– – 0.61% 23
2022
Q2 		$1.5M Sell
19,438
-104
-0.5% -$7.92K 0.62% 23
2022
Q1 		$1.43M Sell
19,542
-1,417
-7% -$95.1K 0.48% 27
2021
Q4 		$1.31M Sell
20,959
-367
-2% -$21.5K 0.39% 36
2021
Q3 		$1.26M Sell
21,326
-115
-0.5% -$7.57K 0.4% 38
2021
Q2 		$1.43M Sell
21,441
-414
-2% -$27K 0.44% 30
2021
Q1 		$1.38M Sell
21,855
-768
-3% -$47.8K 0.43% 35
2020
Q4 		$1.4M Buy
22,623
+7,735
+52% +$476K 0.46% 38
2020
Q3 		$898K Sell
14,888
-146
-1% -$8.79K 0.34% 55
2020
Q2 		$884K Buy
+15,034
New +$899K 0.36% 46
2019
Q4 		– Sell
-7,677
Closed -$389K – 245
2019
Q3 		$389K Sell
7,677
-792
-9% -$37.2K 0.15% 172
2019
Q2 		$384K Buy
8,469
+338
+4% +$15.7K 0.14% 174
2019
Q1 		$388K Sell
8,131
-8,141
-50% -$406K 0.15% 184
2018
Q4 		$846K Sell
16,272
-650
-4% -$34.9K 0.37% 48
2018
Q3 		$1.05M Sell
16,922
-8
-0% -$475 0.38% 39
2018
Q2 		$937K Buy
16,930
+10,575
+166% +$571K 0.32% 72
2018
Q1 		$402K Buy
+6,355
New +$409K 0.14% 210
2017
Q3 		– Sell
-5,949
Closed -$331K – 321
2017
Q2 		$331K Sell
5,949
-93
-2% -$5.06K 0.12% 246
2017
Q1 		$329K Sell
6,042
-554
-8% -$30.4K 0.11% 248
2016
Q4 		$385K Buy
6,596
+74
+1% +$4.05K 0.14% 201
2016
Q3 		$352K Sell
6,522
-500
-7% -$32.1K 0.13% 210
2016
Q2 		$516K Sell
7,022
-300
-4% -$21.2K 0.21% 128
2016
Q1 		$468K Sell
7,322
-14,248
-66% -$899K 0.2% 136
2015
Q4 		$1.48M Hold
21,570
– – 0.68% 34
2015
Q3 		$1.28M Buy
+21,570
New +$1.37M 0.62% 38
2015
Q1 		– Sell
-24,126
Closed -$1.42M – 263
2014
Q4 		$1.42M Hold
24,126
– – 0.65% 38
2014
Q3 		$1.24M Sell
24,126
-1,132
-4% -$56.5K 0.63% 51
2014
Q2 		$1.23M Buy
25,258
+302
+1% +$14.9K 0.62% 57
2014
Q1 		$1.3M Sell
24,956
-612
-2% -$32.6K 0.6% 44
2013
Q4 		$1.36M Buy
25,568
+1,760
+7% +$89.7K 0.69% 45
2013
Q3 		$1.1M Hold
23,808
– – 0.65% 54
2013
Q2 		$1.06M Buy
+23,808
New +$1.03M 0.63% 55

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIM Investment Management's BMY Position: Q1 2026 in Review

CIM Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 0.44% in Q1 2026, selling an estimated $3.73K and leaving 14,397 shares worth $873K. The position accounts for 0.23% of the portfolio, ranked #69.

CIM Investment Management first reported a position in BMY in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.51M in Q2 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • CIM Investment Management held 14,397 shares of Bristol-Myers Squibb worth $873K as of Q1 2026.
  • CIM Investment Management sold 64 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.73K.
  • Bristol-Myers Squibb made up 0.23% of CIM Investment Management's portfolio in Q1 2026, its #69 holding.
  • CIM Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 46 quarters since.
  • CIM Investment Management's Bristol-Myers Squibb position peaked at $1.51M in Q2 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.